{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:44Z","timestamp":1786988144288,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejpn.2025.07.013","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:15:02Z","timestamp":1753888502000},"page":"42-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["CSF IL-6 in children with neuroinflammatory conditions"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0556-0176","authenticated-orcid":false,"given":"Valeria","family":"Pozzilli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2207-3879","authenticated-orcid":false,"given":"Manori Prasadani","family":"Thambiliyagodage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5979-9337","authenticated-orcid":false,"given":"Kshitij","family":"Mankad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6803-7385","authenticated-orcid":false,"given":"Austen","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ghorashian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4764-229X","authenticated-orcid":false,"given":"Alasdair","family":"Bamford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3899-3015","authenticated-orcid":false,"given":"Cheryl","family":"Hemingway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Kaliakatsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8490-9657","authenticated-orcid":false,"given":"Yael","family":"Hacohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2025.07.013_bib1","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213537","article-title":"Diagnosis and management of children with atypical neuroinflammation","volume":"104","author":"Saucier","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2025.07.013_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cyto.2015.10.001","article-title":"CSF cytokines\/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review","volume":"77","author":"Kothur","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.ejpn.2025.07.013_bib3","first-page":"397","article-title":"Cytokines in the CNS","volume":"248","author":"Marisa","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejpn.2025.07.013_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000330247","article-title":"Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier","volume":"19","author":"Erickson","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.ejpn.2025.07.013_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219987","article-title":"Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers","volume":"14","author":"Liba","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpn.2025.07.013_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161656","article-title":"Utility of CSF cytokine\/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, Anti-NMDAR and enteroviral encephalitis","volume":"11","author":"Kothur","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpn.2025.07.013_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.966766","article-title":"Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases","volume":"13","author":"Jiao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpn.2025.07.013_bib8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/pharmaceutics14051001","article-title":"A comprehensive overview of globally approved JAK inhibitors","volume":"14","author":"Shawky","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpn.2025.07.013_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1231749","article-title":"Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4","volume":"14","author":"Cooray","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpn.2025.07.013_bib10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejpn.2025.07.013_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072399","article-title":"Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases","volume":"8","author":"Wullschleger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpn.2025.07.013_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2024.113681","article-title":"Specimen type validation and establishment of normal cytokine reference intervals in cerebrospinal fluid","volume":"529","author":"Martins","year":"2024","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejpn.2025.07.013_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109130","article-title":"Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach","volume":"111","author":"Aliyu","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejpn.2025.07.013_bib14","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"108","author":"Chihara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejpn.2025.07.013_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-021-00299-6","article-title":"Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients with hematologic malignancy","volume":"7","author":"Xue","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.ejpn.2025.07.013_bib16","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000841","article-title":"Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology","volume":"7","author":"Fujihara","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.ejpn.2025.07.013_bib17","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200150","article-title":"Dramatic response to Anti-IL-6 receptor therapy in children with life-threatening myelin oligodendrocyte glycoprotein-associated disease","volume":"10","author":"McLendon","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.ejpn.2025.07.013_bib18","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200243","article-title":"Life-threatening MOG antibody-associated hemorrhagic ADEM with elevated CSF IL-6","volume":"11","author":"Virupakshaiah","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.ejpn.2025.07.013_bib19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.27024","article-title":"Cerebrospinal fluid cytokine and chemokine profiles in central nervous system sarcoidosis: diagnostic and immunopathologic insights","volume":"96","author":"Mangioris","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2025.07.013_bib20","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200323","article-title":"Pediatric MOG-Ab-Associated encephalitis: supporting early recognition and treatment","volume":"11","author":"Kim","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.ejpn.2025.07.013_bib21","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001052","article-title":"International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis","volume":"8","author":"Nosadini","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.ejpn.2025.07.013_bib22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jnnp-2014-309388","article-title":"Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus","volume":"86","author":"Sakuma","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejpn.2025.07.013_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ana.26627","article-title":"Cytokines in new-onset refractory status epilepticus predict outcomes","volume":"94","author":"Hanin","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2025.07.013_bib24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ana.25315","article-title":"Neurotoxicity after CTL019 in a pediatric and young adult cohort","volume":"84","author":"Gofshteyn","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2025.07.013_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-024-01100-5","article-title":"Novel strategies to manage CAR-T cell toxicity","author":"Mulvey","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpn.2025.07.013_bib26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/15353702211068840","article-title":"Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?","volume":"247","author":"Liu","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.ejpn.2025.07.013_bib27","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamaneurol.2020.2687","article-title":"Neurologic and radiographic findings associated with COVID-19 infection in children","volume":"77","author":"Abdel-Mannan","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejpn.2025.07.013_bib28","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1002\/ajh.27132","article-title":"Siltuximab administration results in spurious IL-6 elevation in peripheral blood","volume":"99","author":"Mango","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejpn.2025.07.013_bib29","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/glia.23634","article-title":"Microglia responses to interleukin-6 and type I interferons in neuroinflammatory disease","volume":"67","author":"West","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.ejpn.2025.07.013_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/cells10020276","article-title":"Phosphorylation of microglial IRF5 and IRF4 by IRAK4 regulates inflammatory responses to ischemia","volume":"10","author":"Ngwa","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejpn.2025.07.013_bib31","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.3390\/ijms22126442","article-title":"Brain disposition of antibody-based therapeutics: dogma, approaches and perspectives","volume":"22","author":"Kouhi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpn.2025.07.013_bib32","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood-2018-05-846428","article-title":"Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques","volume":"132","author":"Nellan","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ejpn.2025.07.013_bib33","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s10875-023-01500-z","article-title":"JAK inhibition in aicardi-gouti\u00e8res syndrome: a monocentric multidisciplinary real-world approach study","volume":"43","author":"Fr\u00e9mond","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ejpn.2025.07.013_bib34","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1056\/NEJMc2031081","article-title":"JAK inhibition in the aicardi\u2013gouti\u00e8res syndrome","volume":"383","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379825001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379825001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:17:49Z","timestamp":1761963469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379825001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"alternative-id":["S1090379825001254"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2025.07.013","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF IL-6 in children with neuroinflammatory conditions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2025.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}